Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Yakobson

Showing results (51-60 of 67) with videos related to

Pageof 7
Sort By:
Cancers|August 28, 2025
Analysis of Metastases and Second Primary Malignancy Development in Patients with Invasive Transitional Cell Carcinoma of the BladderKeren Rouvinov, Alexander Yakobson, Angela Tiganas, et al.
Cancers|May 25, 2024
Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB StatusWalid Shalata, Natalie Maimon Rabinovich, Abed Agbarya, et al.
Life (Basel, Switzerland)|May 4, 2026
Impact of PD-L1 Status on the Development of Cutaneous Immune-Related Adverse Events in Non-Small-Cell Lung Cancer Patients Receiving ImmunotherapyAlexander Yakobson, Fahed Abu Salamah, Ibrahim Alatawneh, et al.
Diagnostics (Basel, Switzerland)|February 27, 2026
The Transformative Potential of Liquid Biopsies and Circulating Tumor DNA (ctDNA) in Modern OncologyKeren Rouvinov, Rashad Naamneh, Alexander Yakobson, et al.
Frontiers in Oncology|October 7, 2022
Real-world efficacy and safety of mobocertinib in <i>EGFR</i> exon 20 insertion-mutated lung cancerWaleed Kian, Petros Christopoulos, Areen A Remilah, et al.
Case Reports in Oncology|March 29, 2021
Epithelioid Hemangioendothelioma and Epithelioid Hemangioma: Pazopanib as a Potential Salvage TherapyAlexander Yakobson, Wafeek Alguayn, Walid Shalata, et al.
Medical Sciences (Basel, Switzerland)|September 22, 2025
Efficacy of Tyrosine Kinase Inhibitors in ALK and EGFR-Mutated Non-Small Cell Lung Cancer with Brain MetastasesWalid Shalata, Rashad Naamneh, Wenad Najjar, et al.
Medical Sciences (Basel, Switzerland)|April 24, 2026
Survival Outcomes in Lymph Node-Positive Merkel Cell Carcinoma (Stage III): A Comparison Between Known and Unknown Primary Tumors and Their Sun Exposure SitesRonen Brenner, Hanna T Frumin Edri, Sabri El-Saied, et al.
JCO Precision Oncology|September 14, 2020
Vismodegib as First-Line Treatment of Mutated Sonic Hedgehog Pathway in Adult MedulloblastomaWaleed Kian, Laila C Roisman, Iris M Goldstein, et al.
Medical Sciences (Basel, Switzerland)|June 25, 2026
Evaluating the Role of Chemotherapy in Addition to Radiotherapy for High-Risk Merkel Cell CarcinomaRonen Brenner, Hanna T Frumin Edri, Amichay Meirovitz, et al.
Pageof 7

Showing results (51-60 of 67) with videos related to

Sort By:
Pageof 7
Cancers|August 28, 2025
Analysis of Metastases and Second Primary Malignancy Development in Patients with Invasive Transitional Cell Carcinoma of the BladderKeren Rouvinov, Alexander Yakobson, Angela Tiganas, et al.
Cancers|May 25, 2024
Efficacy of Pembrolizumab vs. Nivolumab Plus Ipilimumab in Metastatic NSCLC in Relation to PD-L1 and TMB StatusWalid Shalata, Natalie Maimon Rabinovich, Abed Agbarya, et al.
Life (Basel, Switzerland)|May 4, 2026
Impact of PD-L1 Status on the Development of Cutaneous Immune-Related Adverse Events in Non-Small-Cell Lung Cancer Patients Receiving ImmunotherapyAlexander Yakobson, Fahed Abu Salamah, Ibrahim Alatawneh, et al.
Diagnostics (Basel, Switzerland)|February 27, 2026
The Transformative Potential of Liquid Biopsies and Circulating Tumor DNA (ctDNA) in Modern OncologyKeren Rouvinov, Rashad Naamneh, Alexander Yakobson, et al.
Frontiers in Oncology|October 7, 2022
Real-world efficacy and safety of mobocertinib in <i>EGFR</i> exon 20 insertion-mutated lung cancerWaleed Kian, Petros Christopoulos, Areen A Remilah, et al.
Case Reports in Oncology|March 29, 2021
Epithelioid Hemangioendothelioma and Epithelioid Hemangioma: Pazopanib as a Potential Salvage TherapyAlexander Yakobson, Wafeek Alguayn, Walid Shalata, et al.
Medical Sciences (Basel, Switzerland)|September 22, 2025
Efficacy of Tyrosine Kinase Inhibitors in ALK and EGFR-Mutated Non-Small Cell Lung Cancer with Brain MetastasesWalid Shalata, Rashad Naamneh, Wenad Najjar, et al.
Medical Sciences (Basel, Switzerland)|April 24, 2026
Survival Outcomes in Lymph Node-Positive Merkel Cell Carcinoma (Stage III): A Comparison Between Known and Unknown Primary Tumors and Their Sun Exposure SitesRonen Brenner, Hanna T Frumin Edri, Sabri El-Saied, et al.
JCO Precision Oncology|September 14, 2020
Vismodegib as First-Line Treatment of Mutated Sonic Hedgehog Pathway in Adult MedulloblastomaWaleed Kian, Laila C Roisman, Iris M Goldstein, et al.
Medical Sciences (Basel, Switzerland)|June 25, 2026
Evaluating the Role of Chemotherapy in Addition to Radiotherapy for High-Risk Merkel Cell CarcinomaRonen Brenner, Hanna T Frumin Edri, Amichay Meirovitz, et al.
Pageof 7